Patents Assigned to AGCT GMBH
  • Publication number: 20210071244
    Abstract: The invention relates to a method for amplification of a nucleic acid by a nucleic acid polymerase via two primers, each of which comprise a sequence segment which is bound to the target sequence and a sequence segment which does not bind to the target sequence, wherein the second cannot serve as a template for the polymerase, and two controller oligonucleotides, each of which is complementary to the primers and a segment of the sequence segment synthesized by them and serves to release the synthesized strand from the template. The controllers also comprise modified nucleotide building blocks such that they cannot serve as templates for the activity of the first template-dependent nucleic acid polymerase.
    Type: Application
    Filed: February 28, 2019
    Publication date: March 11, 2021
    Applicant: AGCT GMBH
    Inventors: Dmitry CHERKASOV, Christian GRUNWALD
  • Publication number: 20210071243
    Abstract: The present invention relates to a method for the extension of an oligonucleotide primer with improved specificity using a specific oligonucleotide primer and a controller nucleotide, wherein the controller oligonucleotide enables sequence-specific strand opening of a double strand of extension product and template. The invention further relates to a respective kit for carrying out the method according to the invention.
    Type: Application
    Filed: February 26, 2019
    Publication date: March 11, 2021
    Applicant: AGCT GMBH
    Inventors: Dmitry CHERKASOV, Christian GRUNWALD
  • Publication number: 20210024978
    Abstract: It is disclosed a method for the detection of an amplification of nucleic acids in which substantially use is made of the fact that a pre-defined nucleic acid chain (target sequence) can be multiplied/amplified in the presence of a target sequence-specific activator oligonucleotide. The target sequence-specific activator oligonucleotide causes the separation of re-synthesized complementary primer extension products by means of strand displacement, so that a new primer oligonucleotide can attach to the respective template strand. The thus formed complex of a primer oligonucleotide and a template strand can initiate a new primer extension reaction. The thus formed primer extension products in turn function as templates, so that an exponential amplification reaction results. Amplification is detected by a detection system.
    Type: Application
    Filed: February 25, 2019
    Publication date: January 28, 2021
    Applicant: AGCT GmbH
    Inventors: Christian GRUNWALD, Dmitry CHERKASOV, Norbert BASLER, Claus BECKER, Hans-Joerg HESS, Andreas MÜLLER-HERMANN
  • Patent number: 10612082
    Abstract: A method for amplification of nucleic acids in which substantially use is made of the fact that a pre-defined nucleic acid chain (target sequence) can be multiplied/amplified in the presence of a target sequence-specific activator oligonucleotide. The target sequence-specific activator oligonucleotide causes the separation of re-synthesized complementary primer extension products by strand displacement, so that a new primer oligonucleotide can attach to the respective template strand. The thus formed complex of a primer oligonucleotide and a template strand can initiate a new primer extension reaction. The thus formed primer extension products in turn function as templates, so that an exponential amplification reaction results.
    Type: Grant
    Filed: August 21, 2017
    Date of Patent: April 7, 2020
    Assignee: AGCT GmbH
    Inventors: Dmitry Cherkasov, Norbert Basler, Claus Becker, Hans-Joerg Hess, Andreas Mueller-Hermann
  • Patent number: 9994894
    Abstract: The invention relates to a novel method for the enzymatic marking of nucleic acid chains (target sequences) by means of nucleotide conjugates. Said nucleotide conjugates are able, under reaction conditions, to specifically bind to the target sequence and integrate into the complementary growing strand by means of a polymerase. The nucleic acid chains marked by such conjugates can be bound to the solid phase. The marking can be carried out parallel to the enzymatic amplification of target sequences.
    Type: Grant
    Filed: April 26, 2012
    Date of Patent: June 12, 2018
    Assignee: AGCT GMBH
    Inventors: Dmitry Cherkasov, Claus Becker, Norbert Basler, Andreas Muller-Hermann, Petra Van Husen